SmartLabs' goal is to minimize any administrative and logistical hurdles your team faces on its way to reaching important research milestones. We provide a turnkey laboratory environment that allows you to focus on scientific discovery from day one.
Meet the Team
Seth has more than 17 years of industry experience that combines business development, corporate advisory services, and the founding of life science companies.
As Managing General Partner of Vectur LLC and as Principal at TSG Partners, Seth developed growth strategies and worked on a wide range of tactical mandates for leading life science companies. He was co-founder of Molecularware, Inc., a life science information company. Prior to that, he served as a business development executive at Packard Bioscience.
Seth holds a PhD in Molecular Biology from Johns Hopkins University and an MBA from the MIT Sloan School of Management.
Amrit is a recognized leader and entrepreneur in life sciences. He is the founder of Advanced Peptides, a specialty contract research organization focused on peptide chemistry.
Amrit holds numerous patents, has successfully created five companies, and has been involved in many FDA clinical trials. In 2017, INC Magazine named Amrit one of the "Top 20 Healthcare Innovators and Entrepreneurs".
VP, Advanced Services
Hans has decades of experience in life science and technology companies while holding a variety of technical and management positions. Throughout his career, he has focused on commercializing advanced technology projects in partnership with corporations and VCs.
Hans holds a PhD in Biochemistry from the University of Bern, Switzerland and a Master's in Biochemistry and Microbiology from the Federal Institute of Technology in Zürich, Switzerland.
From newly funded startups to international pharma groups, SmartLabs supports companies as they reach critical milestones. Whether they have one employee or 60, our members look to be part of the major life science hubs — and we get them up and running in just weeks.
- Cue Biopharma was founded at SmartLabs and IPO'd in less than 30 months
- CRISPR Biopharma closed on $450M in pharma deals in its first six months in our space
- Editas and SolidBio used SmartLabs as a means to hit major milestones prior to going public